Stay updated on Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (Revision: v3.5.4) was added to the Record History, updating the revision timeline and replacing the previous revision (v3.5.3).SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision label was updated from v3.5.2 to v3.5.3, indicating a new release entry for the record history. This change reflects a minor update to the page's metadata rather than a modification to the trial details.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0. This reflects version control updates and does not alter study content or page functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record history now shows the addition of Revision v3.5.0 and the deletion of Revision v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check98 days agoChange DetectedThe record history shows new entries for Active, not recruiting status, Study Status, Recruitment Status, and Contacts/Locations, with a revision noted as v3.4.2 on 2026-02-05.SummaryDifference2%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.